Effect of Surgical Site Infections on Patient Reported Cosmetic Outcomes in Dermatologic Surgery

Completed

• Conditions: Patient Satisfaction; Surgical Site Infection
• Interventions: Other: SCAR-Q survey

• Registration Number: NCT04744961
• Lead Sponsor: Region Skane

Brief Summary

This study involves surveying two matched groups of patients that underwent dermatologic surgery at our department. One group had a documented surgical site infection and the other didn't. All patients will be asked to complete a questionnaire in which they assess the physical appearance of their scars and its psychosocial impact. Results will be compared between the groups.

Detailed Description

65 patients with a documented surgical site infection will be compared to 65 patients with normal wound healing in terms of patient reported outcome regarding scar physical appearance and psychosocial impact using SCAR-Q questionnaire.

Study Timeline

• Study First Submitted: 2021-02-03
• Study First Submitted QC: 2021-02-05
• Study First Posted: 2021-02-09
• Study Start: 2021-02-24
• Status Verified: 2021-05
• Primary Completion: 2021-05-17
• Study Completion: 2021-05-17
• Last Update Submitted: 2021-05-17
• Last Update Posted: 2021-05-18

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 114

Inclusion Criteria

• Patient above 18 years of age that underwent a dermatosurgical procedure at our department between march 2017 and march 2020.

Exclusion Criteria

• Patients assessed as not suitable for telephone survey due to hearing disabilities or cognitive impairment

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Surgical site infections	SCAR-Q survey	-
Normal would healing	SCAR-Q survey	-

Primary Outcome Measures

Name	Time	Method
Comparing mean values of SCAR-Q scores in both groups	3 months	Scar-Q (http://qportfolio.org/scar-q/) is a patient reported outcome instrument in which scars will be assessed in terms of scar appearance and psychosocial impact. Scores will range from 0 (worst) to 100 (best). Scores will be compared between the two groups using either parametric or non-parametric tests depending on the distribution of the results.

Secondary Outcome Measures

Name	Time	Method
Association between patient characteristics and SCAR-Q scores	3 months	Score values (0-100) will be correlated to the following patient characteristics (gender, age, type of surgical procedure, anatomic location, and diagnosis of excised lesion)

Trial Locations

Locations (1)

Department of dermatology, Skåne university hospital; 🇸🇪 Lund, Sweden